Europe | Global Lung Cancer Coalition

Screening for the Biggest Cancer Killer: Beating Lung Cancer Through Screening Guidelines?

Author: Prof. Denis Horgan, PhD, LLM, MSc, BCL, executive director of the European Alliance for Personalised Medicine, Brussels, Belgium. Publication Source: IASLC News Country: Europe Date: June 2021 Summary of Content: A summary of the evolution of European lung cancer screening policies and a call to action to policymakers. Link to Document: https://www.iaslc.org/iaslc-news/ilcn/screening-biggest-cancer-killer-beating-lung-cancer-through-screening-guidelines

Lung cancer screening: the time is now

Author: Aoife McNamara, the Irish Cancer Society, and Suzanne Wait, the Health Policy Partnership Publication Source: The Health Policy Partnership Country: Europe and UK Date: November 2021 Summary of Content: This article makes the case for lung cancer screening Link to Document: https://www.healthpolicypartnership.com/lung-cancer-screening-the-time-is-now/

Lung Cancer in Germany

Author: Nikolaj Frost MD et al Publication Source: JTO Country: Germany Date: June 2022 Summary of content: An overview of the healthcare systems and provisions in Germany since reunification. The article looks at most aspects of lung oncology in Germany, with a section devoted specifically to lung cancer screening. In their conclusion, the authors state […]

Financial Toxicity of Lung Cancer in the Netherlands

Author: Anne-Marie C. Dingemans, MD, PhD, Jente Klok, MSc, Lidia Barberio, MSc, Vivian Engelen, PhD, and Roel Masselink, MSc Publication Source: ILC News Country: Netherlands Summary of Content: This article outlines the financial burden placed on many people following the diagnosis of lung cancer. Information and financial support can help prevent or reduce financial difficulties. […]

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

Author: Paci et al. Publication Source: British Medical Journal Country: Europe Date: September 2017 Summary of Content: This study evaluates the effectiveness of lung cancer screening to reduce mortality in Italy, and is contributing to the European evaluation of screening. Link to Document: https://thorax.bmj.com/content/72/9/825.long (Access Required)

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

Author: Pastorino et al. Publication Source: Annals of Oncology Country: Europe Date: July 2019 Summary of Content: This study evaluates the benefits of lung cancer screening beyond five years and its impact on mortality after 10 years. Link to Document: https://academic.oup.com/annonc/article/30/7/1162/5425325

Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial

Author: Becker et al. Publication Source: International Journal of Cancer Country: Europe Date: June 2019 Summary of Content: This study analyses data from a German lung cancer screening trial which compared five annual rounds of lung cancer screening. Link to Document: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.32486 (Access Required)

Implementing Lung Cancer Screening in Europe: Taking a Systems Approach

Author: Suzanne Wait, PhD et al Publication Source: JTO Clinical and Research Reports Country: Pan-Europe Date: April 2022 Summary of Content: To date, Poland, Croatia, Italy, and Romania are the only European countries to commit to large-scale implementation of targeted LDCT screening. Using a health systems approach, this article evaluates key factors needed to enable the […]

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

Author: Wille et al. Publication Source: American Journal of Respiratory and Critical Care Medicine Country: March 2016 Date: N/A Summary of Content: This study reports the findings of the Danish Lung Cancer Screening Trial five years after the last screening round. Link to Document: https://www.atsjournals.org/doi/abs/10.1164/rccm.201505-1040OC